Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Sep;64(8):551-67.
doi: 10.1016/j.curtheres.2003.08.006.

Effects of garcinia cambogia (Hydroxycitric Acid) on visceral fat accumulation: a double-blind, randomized, placebo-controlled trial

Affiliations

Effects of garcinia cambogia (Hydroxycitric Acid) on visceral fat accumulation: a double-blind, randomized, placebo-controlled trial

Kohsuke Hayamizu et al. Curr Ther Res Clin Exp. 2003 Sep.

Abstract

Background: (-)-Hydroxycitric acid (HCA) is an active ingredient extracted from the rind of the Indian fruit Garcinia cambogia. It inhibits adenosine triphosphate citrate lyase and has been used in the treatment of obesity.

Objective: The primary end point of this study was the effects of 12 weeks of G cambogia extract administration on visceral fat accumulation. The secondary end points were body indices (including height, body weight, body mass index [BMI], waist and hip circumference, and waist-hip ratio) and laboratory values (including total cholesterol, triacylglycerol, and free fatty acid).

Methods: This study was performed according to a double-blind, randomized, placebo-controlled, parallel-group design. Subjects aged 20 to 65 years with a visceral fat area >90 cm(2) were enrolled. Subjects were randomly assigned to receive treatment for 12 weeks with G cambogia (containing 1000 mg of HCA per day) or placebo. At the end of the treatment period, both groups were administered placebo for 4 weeks to assess any rebound effect. Each subject underwent a computed tomography scan at the umbilical level at -2, 0, 12, and 16 weeks.

Results: Forty-four subjects were randomized at baseline, and 39 completed the study (G cambogia group, n = 18; placebo group, n = 21). At 16 weeks, the G cambogia group had significantly reduced visceral, subcutaneous, and total fat areas compared with the placebo group (all indices P<0.001). No severe adverse effect was observed at any time in the test period. There were no significant differences in BMI or body weight at week 12, but there were slight numeric decreases in body weight and BMI in men. There were no signs of a rebound effect from week 12 to week 16.

Conclusion: G cambogia reduced abdominal fat accumulation in subjects, regardless of sex, who had the visceral fat accumulation type of obesity. No rebound effect was observed. It is therefore expected that G cambogia may be useful for the prevention and reduction of accumulation of visceral fat.

Keywords: Garcinia cambogia; computed tomography scan; hydroxycitric acid; visceral fat accumulation.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Protocol of the efficacy test of Garcinia cambogia. Subjects received no treatment during a 2-week run-in period. CT = computed tomography.
Figure 2.
Figure 2.
Study flow diagram.

Similar articles

Cited by

References

    1. The National Nutrition Survey in Japan 2000. Dai-ichi Shuppan Publishing; Tokyo, Japan: 2002. Ministry of Health, Labour and Welfare Japan. 59–60.
    1. Déspres J.P, Lamarche B. Effects of diet and physical activity on adiposity and body fat distribution: Implications for the prevention of cardiovascular disease. Nutr Res Rev. 1993;6:137–159. - PubMed
    1. Bray G.A. Complications of obesity. Ann Intern Med. 1985;103:1052–1062. - PubMed
    1. Health implications of obesity. National Institutes of Health Consensus Development Conference Statement. Ann Intern Med. 1985;103:1073–1077. - PubMed
    1. Kissebah A.H, Freedman D.S, Peiris A.N. Health risks of obesity. Med Clin North Am. 1989;73:111–138. - PubMed

LinkOut - more resources